Liminatus Pharma, Inc. (LIMN)
1.43
+0.36
(+33.64%)
USD |
NASDAQ |
Feb 04, 16:00
1.52
+0.09
(+6.29%)
After-Hours: 20:00
Liminatus Pharma Price : 1.43 for Feb. 4, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CDT Equity, Inc. | 1.06 |
| LENZ Therapeutics, Inc. | 14.62 |
| Oruka Therapeutics, Inc. | 33.00 |
| Maze Therapeutics, Inc. | 48.14 |
| MapLight Therapeutics, Inc. | 16.80 |
Price Related Metrics
| PEG Ratio | -0.2245 |
| Earnings Yield | -12.96% |
| Market Cap | 38.70M |
| PEGY Ratio | -0.2245 |